Key Developments: Elekta publ AB (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

88.80SEK
11:29am EST
Change (% chg)

-0.10kr (-0.11%)
Prev Close
88.90kr
Open
89.30kr
Day's High
89.95kr
Day's Low
88.50kr
Volume
1,292,512
Avg. Vol
2,317,227
52-wk High
100.50kr
52-wk Low
63.95kr

Search Stocks

Latest Key Developments (Source: Significant Developments)

Elekta publ AB announces acquisition of Mesi Medikal
Thursday, 24 Jul 2014 02:08am EDT 

Elekta publ AB:Has acquired Mesi Medikal A.S., distributor of radiation oncology solutions in Turkey.Mesi Medikal will change its name to Elekta and will be a fully owned company.Financial terms were not disclosed.  Full Article

Uppsala University Hospital and Elekta to further cancer research in Sweden
Thursday, 10 Jul 2014 02:00am EDT 

Elekta publ AB:Says Uppsala University Hospital (UUH) and Elekta today announces that they have signed an agreement to jointly work at the forefront of imaging in cancer care research.With this research agreement, Uppsala University Hospital and Elekta seek to contribute to the field of personalized care by using Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET).In the future MRI potentially enables doctors to treat cancer with radiation while seeing in real time where the tumor is and correct for movement.With this joint research agreement Uppsala intends to become the first hospital in Sweden to receive a clinical system, once it has been approved by the regulatory authorities (CE-mark).To prepare for this, UUH has already started the building of new facilities, with bunkers that are capable of receiving such treatment units of the future.  Full Article

Elekta publ AB comments on FY 2014/2015 guidance
Tuesday, 17 Jun 2014 07:00am EDT 

Elekta publ AB:For the fiscal year 2014/2015 net sales is expected to grow by 7-9 percent in local currency, including a weak first quarter, said Elekta President and CEO, Niklas Savander.He underpinned the company's ambition to return to growth levels above 10 percent.FY 2013/2014 revenue of 10,694 million Swedish crowns.FY 2014/2015 revenue of 11,564 million crowns - Thomson Reuters I/B/E/S Estimates.  Full Article

Institute of Cancer Research joins Elekta and Philips' consortium on development of MRI-guided therapy system
Thursday, 5 Jun 2014 01:30am EDT 

Elekta publ AB:Says the Institute of Cancer Research (ICR) joins Elekta and Philips' research consortium on development of MRI-guided radiation therapy.ICR is a cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust.  Full Article

Elekta proposes ordinary and extraordinary dividend for FY 2013/2014
Wednesday, 28 May 2014 01:30am EDT 

Elekta publ AB:Proposes ordinary dividend of 1.50 Swedish crowns per share for FY 2013/2014.Proposes extraordinary dividend of 0.50 crowns per share.Paid ordinary dividend of 1.50 Swedish crowns per share and extraordinary dividend of 0.50 crowns per share for FY 2012/2013.  Full Article

Elekta issues FY 2014/2015 guidance in line with analysts' estimates
Wednesday, 28 May 2014 01:30am EDT 

Elekta publ AB:Expects FY 2014/2015 net sales to grow by 7-9 percent in local currency.Expects FY 2014/2015 EBITA to grow by 10 percent or more in local currency.FY 2013/2014 net sales 10,694 million Swedish crowns, EBITA 2,183 million crowns.FY 2014/2015 revenue 11,921 million crowns-Thomson Reuters I/B/E/S.  Full Article

Elekta publ AB receives order by the Centre hospitalier de l’Universite de Montreal
Wednesday, 7 May 2014 01:30am EDT 

Elekta publ AB:Says it has signed an agreement to provide the Centre hospitalier de l'Universite de Montreal (CHUM) with advanced linear accelerators and software.The order, resulting from a tender process, is valued at more than $20 million and was booked during Elekta’s fourth quarter of its fiscal year 2013/14.Says, to increase the efficiency of its new integrated cancer center, the CHUM has chosen Elekta’s MOSAIQ oncology information system.Says the system aims at managing the complete spectrum of oncology treatments in a single patient record accessible by its 17 multi-disciplinary teams across multiple locations.  Full Article

Elekta says Dutch medical center begins installation of high-field MRI-guided radiation therapy system
Saturday, 5 Apr 2014 01:30am EDT 

Elekta publ AB:Says the initial components of the world’s first high-field magnetic resonance imaging (MRI) guided radiation therapy system are being installed at UMC Utrecht.Believes the integration of Philips 1.5 Tesla MRI system with Elekta radiation therapy system could allow doctors to adapt radiation therapy during the procedure, increasing treatment accuracy, potentially reducing side effects and enabling increases in the therapeutic dose.Development of the high-field MRI-guided linear accelerator (linac) is the mission of the MR Linac Research Consortium headed by Elekta and supported by Philips.  Full Article

Elekta receives order from NHS Supply Chain
Friday, 4 Apr 2014 10:30am EDT 

Elekta publ AB:Receives order for several Elekta Synergy linear accelerators with Agility multileaf collimators as well as X-ray Volume Imaging (XVI) systems and licenses to connect to Elekta's MOSAIQ oncology information system.The order comes from NHS Supply Chain and is worth 19 million British pounds.  Full Article

Elekta revises downwards FY 2013/2014 financial guidance
Friday, 21 Feb 2014 01:40am EST 

Elekta publ AB:Revises downwards FY 2013/2014 financial guidance.Expects FY 2013/2014 net sales to grow by about 7 percent in local currency against earlier forecasted growth of more than 10 percent compared with last year.Expects FY 2013/2014 EBITA to grow by about 3 percent in local currency against earlier forecasted growth of about 10 percent compared with last year.Reported net sales of 10,339 million Swedish crowns for FY 2013.FY 2013/2014 revenue 11,318 million Swedish crowns - Thomson Reuters I/B/E/S Estimates.  Full Article

Search Stocks